Literature DB >> 1901127

Cytokine stimulated endothelin release from endothelial cells.

S M Kanse1, K Takahashi, H C Lam, A Rees, J B Warren, M Porta, P Molinatti, M Ghatei, S R Bloom.   

Abstract

Endothelin release from bovine endothelial cells of the aorta, pulmonary artery, and retinal microvessels was measured in response to various cytokines. Transforming growth factor beta (0.05-5 ng/ml) was found to be a potent stimulator (3-4 fold increase) of endothelin secretion in all three cell types. Tumour necrosis factor alpha (0.1-10 ng/ml) and interferon gamma (8-800 U/ml) had a small (1.5-2 fold increase) but significant effect on endothelin secretion from endothelial cells of large vessels but not the retinal microvessels. Interleukin-1 beta, Interleukin-6 and interleukin-8 at various doses did not affect endothelin secretion. These effects were observed at various time points from 6-24 hrs and indicate that of the cytokines tested, only transforming growth factor beta has a potent effect on endothelin release from endothelial cells of different organs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901127     DOI: 10.1016/0024-3205(91)90434-d

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 2.  Chronic heart failure and the immune system.

Authors:  Daniela Mari; Federica Di Berardino; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

3.  Coronary vasoconstriction in vitro in the hearts of polyarthritic rats: effectiveness of in vivo treatment with the endothelin receptor antagonist SB 209670.

Authors:  P Klemm; T D Warner; D Willis; A R Moore; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

4.  Rickettsial stimulation of endothelial platelet-activating factor synthesis.

Authors:  T S Walker; G E Mellott
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes.

Authors:  Christelle Mérial-Kieny; Michel Lonchampt; Francis Cogé; Patrick Verwaerde; Jean-Pierre Galizzi; Jean A Boutin; Max Lafontan; Nigel Levens; Jean Galitzky; Michel Félétou
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

6.  Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines.

Authors:  P Klemm; T D Warner; T Hohlfeld; R Corder; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Granulocyte-macrophage colony-stimulating factor and interleukin-3 potentiate interferon-gamma-mediated endothelin production by human monocytes: role of protein kinase C.

Authors:  B Salh; K Hoeflick; W Kwan; S Pelech
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

8.  Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.

Authors:  S M Gardiner; J E March; P A Kemp; J J Mullins; T Bennett
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  Enhancement of the haemodynamic effects of NG-monomethyl-L-arginine by transforming growth factor-beta 1 in conscious, normal, but not endotoxaemic, rats.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

10.  Cell and molecular regulation of endothelin-1 production during hepatic wound healing.

Authors:  Rong Shao; Zengdun Shi; Philip J Gotwals; Victor E Koteliansky; Jacob George; Don C Rockey
Journal:  Mol Biol Cell       Date:  2003-04-17       Impact factor: 4.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.